SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001126234-24-000041
Filing Date
2024-04-12
Accepted
2024-04-12 17:01:26
Documents
5
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A lumo-def14ax2024.htm DEF 14A 642197
2 chart-5260dab7f8904f80883.jpg GRAPHIC 105809
3 chart-75154044b026439a88b.jpg GRAPHIC 108075
4 lumospharmainc_vxautoxprxy.jpg GRAPHIC 1978766
5 lumospharmainc_vxautoxprxya.jpg GRAPHIC 1558715
  Complete submission text file 0001126234-24-000041.txt   5793521
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35342 | Film No.: 24842215
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)